The global Positron Emission Tomography (PET) market is set to witness a growth rate of 5% in the next 5 years. Growing prevalence of chronic diseases; technological advancements in ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering ...

(HealthDay News) — Intranasal administration of [ 68 Ga]Ga-NOTA-insulin is safe and delivers insulin to multiple brain regions, according to a study published online July 23 in Alzheimer’s & Dementia: ...

Access Engineering PLC is poised to commence production at Sri Lanka’s first radiopharmaceutical plant by early next year, a landmark venture expected to revolutionise cancer diagnosis and treatment ...

Traditionally, the diagnosis of Alzheimer’s disease has been based on informant interviews and clinical assessments of memory, cognition, behaviour, and mood. To increase diagnostic confidence, ...

Learn how PET study shows safe, targeted brain delivery of intranasal insulin, a critical step for future Alzheimer’s ...

The company presented new data from its Alzheimer’s disease research efforts across its diagnostics and pharmaceutical ...

With multiple clinical trials and approval applications in train, nuclear medicine superstar Telix Pharmaceuticals (ASX:TLX) ...

More than 500 nuclear medicine facilities are available in the government and private sectors, Union Minister of State for ...

Mayo Clinic Jacksonville supports a blood test for to diagnose Alzheimer's while Baptist Health implanted its first atrial ...

Are men’s and women’s hearts that different? Yes, they are, and knowing those differences could save a woman’s life.